NPI: 1255506036 · SAN MARCOS, CA 92069 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/23/2008
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/23/2008 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 19,855 | $2.95M |
| 2019 | 21,160 | $1.91M |
| 2020 | 18,358 | $1.21M |
| 2021 | 21,486 | $1.50M |
| 2022 | 21,964 | $1.73M |
| 2023 | 21,572 | $2.51M |
| 2024 | 23,692 | $2.82M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 73,536 | 5,396 | $13.30M |
| 90945 | 4,412 | 366 | $968K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 23,439 | 2,321 | $140K |
| A4657 | Syringe, with or without needle, each | 4,774 | 1,980 | $60K |
| 0250 | 6,693 | 540 | $41K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 12,406 | 1,195 | $37K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,988 | 1,328 | $33K |
| J1756 | Injection, iron sucrose, 1 mg | 9,069 | 2,981 | $30K |
| 82728 | 1,876 | 1,729 | $15K | |
| 82108 | 346 | 333 | $6K | |
| 83970 | 1,223 | 1,157 | $2K | |
| 90747 | 13 | 13 | $804.67 | |
| 83550 | 1,655 | 1,511 | $452.79 | |
| 90674 | 114 | 114 | $366.03 | |
| 82607 | 70 | 68 | $349.08 | |
| 83540 | 1,925 | 1,772 | $338.17 | |
| 82746 | 64 | 62 | $245.83 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 464 | 353 | $217.62 |
| 85041 | 1,766 | 1,663 | $106.29 | |
| 85048 | 1,767 | 1,664 | $90.07 | |
| 85045 | 226 | 217 | $80.37 | |
| G0008 | Administration of influenza virus vaccine | 38 | 37 | $5.46 |
| 82947 | 46 | 43 | $3.32 | |
| 90662 | 60 | 60 | $0.00 | |
| 90661 | 19 | 19 | $0.00 | |
| 82570 | 46 | 25 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 52 | 52 | $0.00 |